Literature DB >> 29404080

Comparison of Patients with Community-Acquired Pneumonia Who Did and Did not Receive Treatment in Accordance with the 2009 Pneumonia Guideline of Turkish Thoracic Society.

Öznur Kılıç Soylar1, Oğuz Kılınç1, Hülya Ellidokuz2.   

Abstract

OBJECTIVES: The purpose of our study was to compare community-acquired pneumonia (CAP) patients who were and were not administered treatment in accordance with the Turkish Thoracic Society (TTS) 2009 pneumonia guideline in terms of hospital stay length, treatment cost, and treatment efficacy.
MATERIAL AND METHODS: Patients who were admitted to our hospital and who were diagnosed with CAP were included in the study. Demographic characteristics of the patients, symptoms at the time of diagnosis, physical examination, laboratory and radiological findings, treatments, response to treatment at follow-up, length of hospital stay, and direct cost of treatment were recorded in the TTS pneumonia database (TURCAP: TURKEY Community Acquired Pneumonia). Taking into consideration the "Turkish Thoracic Society Consensus Report on the Diagnosis and Treatment of Community-acquired pneumonia in Adults (2009)," the patients recorded in the database were evaluated in terms of conformity to the guideline.
RESULTS: This present study included 156 patients diagnosed with CAP. Sixty-six patients (42.3%) were females, and 96 (57.7%) were males, and the mean age of the patients was 70.4 years. The most common symptoms on admission were cough (94.9%), expectoration of purulent sputum (77.6%), and fever (58%). Comorbid diseases were chronic obstructive pulmonary disease (COPD; 29.5%), asthma (3.2%), lung cancer (8.3%), cardiovascular diseases (32.7%), and diabetes mellitus (12.8%). It was observed that 67.3% of the patients received treatment in accordance with the guideline. No significant difference was found in terms of gender and symptoms between the groups that received and did not receive treatment in accordance with the guideline. The mean age of the patients who received treatment according to the guideline was higher than that of the patients who did not receive treatment according to the guideline; COPD was more frequent in the group of patients who received treatment according to the guideline. Pneumonia Severity Index and Confusion, Urea, Respiratory rate, Blood pressure-Age>65 scores of the patients who were treated according to the guideline was higher and treatment resulted in death in 8% of these patients.
CONCLUSION: Hospital stay length, treatment cost, and treatment efficacy were similar in patients who were and were not administered treatment in accordance with the guideline.

Entities:  

Keywords:  Community-acquired pneumonia; adherence with guideline; pneumonia treatment guideline

Year:  2015        PMID: 29404080      PMCID: PMC5783062          DOI: 10.5152/ttd.2015.4437

Source DB:  PubMed          Journal:  Turk Thorac J        ISSN: 2148-7197


  6 in total

1.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

2.  An audit of inpatient management of community-acquired pneumonia in Oman: a comparison with regional clinical guidelines.

Authors:  Seif Salem Al-Abri; Said Al-Maashani; Ziad A Memish; Nick J Beeching
Journal:  J Infect Public Health       Date:  2012-04-20       Impact factor: 3.718

3.  Antibiotic therapy and 48-hour mortality for patients with pneumonia.

Authors:  Eric M Mortensen; Marcos I Restrepo; Antonio Anzueto; Jacqueline A Pugh
Journal:  Am J Med       Date:  2006-10       Impact factor: 4.965

4.  Community acquired pneumonia and direct hospital cost.

Authors:  Sibel Doruk; Kemal Can Tertemiz; Nuray Kömüs; Eyüp Sabri Uçan; Oğuz Kilinç; Can Sevinç
Journal:  Tuberk Toraks       Date:  2009

5.  Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia.

Authors:  Drahomir Aujesky; Thomas E Auble; Donald M Yealy; Roslyn A Stone; D Scott Obrosky; Thomas P Meehan; Louis G Graff; Jonathan M Fine; Michael J Fine
Journal:  Am J Med       Date:  2005-04       Impact factor: 4.965

Review 6.  Adherence to guidelines for community-acquired pneumonia: does it decrease cost of care?

Authors:  Patricia D Brown
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.